207 related articles for article (PubMed ID: 24761390)
1. Cloning, expression, purification and characterisation of Erwinia carotovora L-asparaginase in Escherichia coli.
Pourhossein M; Korbekandi H
Adv Biomed Res; 2014; 3():82. PubMed ID: 24761390
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional insights into Erwinia carotovora L-asparaginase.
Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
[TBL] [Abstract][Full Text] [Related]
3. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase.
Kotzia GA; Labrou NE
J Biotechnol; 2005 Oct; 119(4):309-23. PubMed ID: 15951039
[TBL] [Abstract][Full Text] [Related]
4. [Purification and properties of recombinant Erwinia carotovora L-asparaginase expressed in E.coli cells].
Borisova AA; El'darov MA; Zhgun AA; Aleksandrova SS; Omel'ianiuk NM; Sokov BN; Berezov TT; Sokolov NN
Biomed Khim; 2003; 49(5):502-7. PubMed ID: 16119104
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of the Erwinia chrysanthemi asparaginase gene in Escherichia coli and Erwinia carotovora.
Gilbert HJ; Blazek R; Bullman HM; Minton NP
J Gen Microbiol; 1986 Jan; 132(1):151-60. PubMed ID: 3011958
[TBL] [Abstract][Full Text] [Related]
6. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
[TBL] [Abstract][Full Text] [Related]
7. Crystallization and preliminary crystallographic analysis of L-asparaginase from Erwinia carotovora.
Wikman LE; Krasotkina J; Kuchumova A; Sokolov NN; Papageorgiou AC
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Apr; 61(Pt 4):407-9. PubMed ID: 16511054
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression and characterization of l-asparaginase from Withania somnifera L. for large scale production.
Oza VP; Parmar PP; Patel DH; Subramanian RB
3 Biotech; 2011 Jul; 1(1):21-26. PubMed ID: 22558532
[TBL] [Abstract][Full Text] [Related]
9. [Cross-immunogenicity of various bacterial L-asparaginases].
D'iakov IN; Pokrovskiĭ VS; Sannikova EP; Bulushova NV; Pokrovskaia MV; Aleksandrova SS
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):100-4. PubMed ID: 25816523
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
Ridgway D; Neerhout RC; Bleyer A
Cancer; 1989 Feb; 63(3):561-3. PubMed ID: 2643458
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification, and characterization of asparaginase II from Saccharomyces cerevisiae in Escherichia coli.
Lopes W; Santos BAFD; Sampaio ALF; Gregório Alves Fontão AP; Nascimento HJ; Jurgilas PB; Torres FAG; Bon EPDS; Almeida RV; Ferrara MA
Protein Expr Purif; 2019 Jul; 159():21-26. PubMed ID: 30836141
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines.
Saeed H; Hemida A; El-Nikhely N; Abdel-Fattah M; Shalaby M; Hussein A; Eldoksh A; Ataya F; Aly N; Labrou N; Nematalla H
Int J Biol Macromol; 2020 Aug; 156():812-828. PubMed ID: 32311402
[TBL] [Abstract][Full Text] [Related]
13. Anticancer Activity of Extremely Effective Recombinant L-Asparaginase from
Darwesh DB; Al-Awthan YS; Elfaki I; Habib SA; Alnour TM; Darwish AB; Youssef MM
J Microbiol Biotechnol; 2022 May; 32(5):551-563. PubMed ID: 35354764
[TBL] [Abstract][Full Text] [Related]
14. [Oligomerization of L-asparaginase from Erwinia carotovora].
Mezentsev IuV; Mol'nar AA; Gnedenko OV; Krasotkina IuV; Sokolov NN; Ivanov AS
Biomed Khim; 2006; 52(3):258-71. PubMed ID: 16898584
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.
Duval M; Suciu S; Ferster A; Rialland X; Nelken B; Lutz P; Benoit Y; Robert A; Manel AM; Vilmer E; Otten J; Philippe N
Blood; 2002 Apr; 99(8):2734-9. PubMed ID: 11929760
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases.
Pokrovsky VS; Kazanov MD; Dyakov IN; Pokrovskaya MV; Aleksandrova SS
BMC Cancer; 2016 Feb; 16():89. PubMed ID: 26867931
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.
Saeed H; Hemida A; Abdel-Fattah M; Eldoksh A; Shalaby M; Nematalla H; El-Nikhely N; Elkewedi M
Protein Expr Purif; 2021 May; 181():105820. PubMed ID: 33440252
[TBL] [Abstract][Full Text] [Related]
18. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
[TBL] [Abstract][Full Text] [Related]
19. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
[TBL] [Abstract][Full Text] [Related]
20.
Van Trimpont M; Schalk AM; De Visser Y; Nguyen HA; Reunes L; Vandemeulebroecke K; Peeters E; Su Y; Lee H; Lorenzi PL; Chan WK; Mondelaers V; De Moerloose B; Lammens T; Goossens S; Van Vlierberghe P; Lavie A
Haematologica; 2023 Feb; 108(2):409-419. PubMed ID: 35979719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
